Lv11
50 积分 2024-03-18 加入
Updated Survival Follow-Up for Phase Ib Trial of the Histone Deacetylase Inhibitor Abexinostat With Pazopanib in Patients With Solid Tumor Malignancies
2小时前
待确认
Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cellsin vitroandin vivo
1个月前
已完结
Programmed cell death protein 1 axis blockade in locally advanced squamous cell carcinoma of the head and neck: Neoadjuvant and adjuvant approaches
2个月前
已完结
Treatment of elderly patients with head and neck cancer in an aging society: Focus on geriatric assessment and surgical treatment
2个月前
已完结
Less Is More: Exploring Neoadjuvant Immunotherapy as a De-escalation Strategy in Head and Neck Squamous Cell Carcinoma Treatment
2个月前
已完结
Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial
7个月前
已完结
Targeting epigenetic deregulations for the management of esophageal carcinoma: recent advances and emerging approaches
8个月前
已完结
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
9个月前
已完结
皖公网安备34019202002308
